Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries MindMed to Participate at May Investor Conferences By: MindMed via Business Wire May 09, 2024 at 16:01 PM EDT Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences: 2024 RBCCM Global Healthcare Conference Format: Fireside Chat Date and Time: Wednesday, May 15, 2024 at 11:00 am EDT Location: New York, NY Webcast Link: 2024 RBCCM Global Healthcare Conference HCW's 2nd Annual BioConnect Investor Conference Format: 1x1 investor meetings only Date: May 20, 2024 Location: New York, NY An audio webcast and replay of the fireside chat at the 2024 RBCCM Global Healthcare Conference will be accessible on MindMed’s Investor Relations website for up to 90 days following the event. About MindMed MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD. View source version on businesswire.com: https://www.businesswire.com/news/home/20240509762996/en/Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
MindMed to Participate at May Investor Conferences By: MindMed via Business Wire May 09, 2024 at 16:01 PM EDT Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences: 2024 RBCCM Global Healthcare Conference Format: Fireside Chat Date and Time: Wednesday, May 15, 2024 at 11:00 am EDT Location: New York, NY Webcast Link: 2024 RBCCM Global Healthcare Conference HCW's 2nd Annual BioConnect Investor Conference Format: 1x1 investor meetings only Date: May 20, 2024 Location: New York, NY An audio webcast and replay of the fireside chat at the 2024 RBCCM Global Healthcare Conference will be accessible on MindMed’s Investor Relations website for up to 90 days following the event. About MindMed MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD. View source version on businesswire.com: https://www.businesswire.com/news/home/20240509762996/en/Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences: 2024 RBCCM Global Healthcare Conference Format: Fireside Chat Date and Time: Wednesday, May 15, 2024 at 11:00 am EDT Location: New York, NY Webcast Link: 2024 RBCCM Global Healthcare Conference HCW's 2nd Annual BioConnect Investor Conference Format: 1x1 investor meetings only Date: May 20, 2024 Location: New York, NY An audio webcast and replay of the fireside chat at the 2024 RBCCM Global Healthcare Conference will be accessible on MindMed’s Investor Relations website for up to 90 days following the event. About MindMed MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD. View source version on businesswire.com: https://www.businesswire.com/news/home/20240509762996/en/